Journal profile · PATHOLOGY
Indian Journal of Pathology and Microbiology
ISSN 0377-4929 · eISSN 0974-5130 · Wolters Kluwer Medknow Publications · INDIA · Quarterly
Indian Journal of Pathology and Microbiology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.68; JCR Q4 (journal website); fully open access; APC about USD 200; median 270 days to acceptance (97 articles, last 24 months); community-reported acceptance: about 95%; 116 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Indian Journal of Pathology and Microbiology is published by Wolters Kluwer Medknow Publications and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Sarcoma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment and Cancer and Skin Lesions, together about 21.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The journal will cover studies related to pathology including morbid anatomy, surgical pathology, clinical pathology, diagnostic cytopathology including gynecologic cytology and aspiration cytology, hematology including immuno-hematology and medical microbiology. The journal gives preference to clinically oriented studies over experimental and animal studies. The Journal would publish peer-reviewed original research papers, case reports, systematic reviews, meta-analysis, letters to the editor and brief communications. Review articles on current topics usually are invited by the editor.
Source: LetPub
Research area (LetPub): PATHOLOGY
Editor-in-chief Bharat RekhiPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Sarcoma Diagnosis and TreatmentMedicine10.3%
- Lymphoma Diagnosis and TreatmentMedicine5.9%
- Cancer and Skin LesionsMedicine5.2%
- Ovarian cancer diagnosis and treatmentMedicine4.8%
- Soft tissue tumor case studiesMedicine4.7%
- Tumors and Oncological CasesMedicine4.7%
- Oral and Maxillofacial PathologyDentistry4.5%
- Salivary Gland Tumors Diagnosis and TreatmentMedicine4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q4 · PATHOLOGY · rank 80/89
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.68LetPub ·
- Impact factor (publisher)
- 0.7Publisher website ·
- CiteScore 2026-06
- 1.2LetPub ·
- SJR 2026-06
- 0.25LetPub ·
- SNIP 2026-06
- 0.43LetPub ·
- h-index
- 28LetPub ·
- h-index
- 49OpenAlex ·
- i10-index
- 847OpenAlex ·
- 2-year mean citedness
- 0.8OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 176LetPub ·
Articles by year OpenAlex count · 3,876 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 99 | 99 | 4 |
| 2025 | 116 | 116 | 68 |
| 2024 | 182 | 182 | 246 |
| 2023 | 331 | 331 | 561 |
| 2022 | 282 | 282 | 627 |
| 2021 | 257 | 257 | 904 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
270 daysMedian, submission to acceptance · P25–P75 152 days – 334 days
- Acceptance to online
- median 86 days (98 articles)
- Submission to online
- median 362 days
- Sample
- 97 articles with submission and acceptance dates (227 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 1 monthLetPub ·
- Average acceptance (community reports)
- 95%LetPub ·
- Submission to publication (journal-reported)
- about 51 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 200 / INR 600 | No | CC BY-NC-SA | |
| OpenAlex | USD 200 | — | — | |
| LetPub | USD 200 | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Medknow Publications
- Country or region
- INDIA
- Language
- English
- Frequency
- Quarterly
- ISSN
- 0377-4929
- Electronic ISSN
- 0974-5130
- Latest issue on the website
- Volume 69, Issue 2 (June 2026)
- Official links
FAQ
Frequently asked questions about Indian Journal of Pathology and Microbiology
What CAS zone is Indian Journal of Pathology and Microbiology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Indian Journal of Pathology and Microbiology is in Zone 4 of Medicine, and in Zone 4 of the minor category Pathology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Indian Journal of Pathology and Microbiology?
The latest impact factor listed by LetPub is 0.68; CiteScore 1.2, h-index 49.
How long does peer review take at Indian Journal of Pathology and Microbiology?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 270 days (interquartile range 152–334 days); authors report an average review time of about 1 month; the community-reported acceptance is “about 95%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Indian Journal of Pathology and Microbiology in?
The journal's website gives JCR Q4; by category, PATHOLOGY Q4 (80/89). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Indian Journal of Pathology and Microbiology?
According to LetPub and DOAJ records, Indian Journal of Pathology and Microbiology is indexed in SCIE, Scopus and DOAJ.
Is Indian Journal of Pathology and Microbiology open access, and what is the APC?
Indian Journal of Pathology and Microbiology is a fully open-access journal. APC about USD 200.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .